Trial · NCT07894042
AI-Powered Sleep Hygiene Mentor for Adults Living With HIV
NCT07894042, Not applicable, Not yet recruiting, Universitas Indonesia
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. AI-Powered Sleep Hygiene Mentor for Adults Living With HIV. Trials, record NCT07894042. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07894042
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- AI-Powered Sleep Hygiene Mentor for Adults Living With HIV
- NCT number
- NCT07894042
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 100 participants, estimated
- Lead sponsor
- Universitas Indonesia
- Conditions
- Sleep Wake Disorders, Sleep Initiation and Maintenance Disorders, HIV Infections
- Interventions
- AI-powered sleep hygiene mentor
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in sleep quality | Baseline (week 0) and week 8 | Change from baseline in the Pittsburgh Sleep Quality Index global score. Range 0 to 21; higher scores indicate poorer sleep quality. |
| Secondary | Insomnia severity | Weeks 0 and 8 | Insomnia Severity Index total score. Range 0 to 28; higher scores indicate more severe insomnia. |
| Secondary | Depression | Weeks 0 and 8 | Depression subscale of the 21-item Depression Anxiety Stress Scales, multiplied by 2. Range 0 to 42; higher scores indicate more depression. |
| Secondary | Anxiety | Weeks 0 and 8 | Anxiety subscale of the 21-item Depression Anxiety Stress Scales, multiplied by 2. Range 0 to 42; higher scores indicate more anxiety. |
| Secondary | Stress | Weeks 0 and 8 | Stress subscale of the 21-item Depression Anxiety Stress Scales, multiplied by 2. Range 0 to 42; higher scores indicate more stress. |
| Secondary | Fatigue | Weeks 0 and 8 | FACIT-Fatigue subscale score. Range 0 to 52; higher scores indicate less fatigue. |
| Secondary | Adherence to antiretroviral therapy | Weeks 0 and 8 | Three-item self-report adherence scale for the past 30 days. Range 0 to 100; higher scores indicate better adherence. |
| Secondary | Perceived usefulness of the mentor | Weeks 0 and 8 | Mean score of study-specific Technology Acceptance Model items on perceived usefulness, developed and validated in Cycle 1; higher scores indicate greater perceived usefulness. |
| Secondary | Perceived ease of use of the mentor | Weeks 0 and 8 | Mean score of study-specific Technology Acceptance Model items on perceived ease of use, developed and validated in Cycle 1; higher scores indicate greater ease of use. |
| Secondary | Health beliefs about sleep | Weeks 0 and 8 | Mean score of study-specific Health Belief Model items on sleep, developed and validated in Cycle 1; higher scores indicate stronger beliefs supporting healthy sleep behaviour. |
1 to 10 of 16Source ClinicalTrials.gov
See all 16 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07894042
GET https://conductscience.org/api/trials/v1/NCT07894042/registered